English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

who were not enrolled in any of the RCTs. In this issue of the Journal, Fujihara et al11 report on clinical outcomes of renal artery stenting in 149 ARAS patients with hypertension and/or renal impairment, revealing a significant BP reduction and stabilization of renal function. Although this is a single-arm study, the results show promise that PTRA may be more beneficial than considered according to the results enal artery stenosis (RAS) leads to renovascular hypertension, a major cause of secondary hypertension, and occurs in approximately 1% of all hypertensive patients in Japan.1 Atherosclerotic RAS (ARAS) is the primary cause in middle-aged and elderly patients, contrasting with fibromuscular dysplasia in younger patients, and usually involves the ostium and proximal one-third of 1 or both renal arteries.2 ARAS is often complicated by other vascular diseases such as peripheral and coronary artery diseases.1 Although many of the patients have normal renal function, hemodynamically significant unilateral or bilateral RAS causes progressive renal failure known as ischemic nephropathy, which may account for 10% of the underlying diseases of endstage renal failure.1,3 In type 2 diabetic patients with suspected severe arteriosclerosis, who represent a major subset of patients with ‘high-risk’ clinical presentations, the presence of ARAS is a significant and independent risk factor for cardiovascular-renal events.4

Renal Angioplasty for Atherosclerotic Renal Artery Stenosis Revisited